JP2013530160A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013530160A5 JP2013530160A5 JP2013512611A JP2013512611A JP2013530160A5 JP 2013530160 A5 JP2013530160 A5 JP 2013530160A5 JP 2013512611 A JP2013512611 A JP 2013512611A JP 2013512611 A JP2013512611 A JP 2013512611A JP 2013530160 A5 JP2013530160 A5 JP 2013530160A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- seq
- composition according
- modification
- antisense oligonucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29678310P | 2010-01-20 | 2010-01-20 | |
| US61/296,783 | 2010-01-20 | ||
| US28254610P | 2010-02-26 | 2010-02-26 | |
| US61/282,546 | 2010-02-26 | ||
| PCT/US2011/021886 WO2012148373A1 (en) | 2010-01-20 | 2011-01-20 | Antimir-451 for the treatment of polycythemias |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013530160A JP2013530160A (ja) | 2013-07-25 |
| JP2013530160A5 true JP2013530160A5 (https=) | 2014-03-06 |
Family
ID=47072618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013512611A Pending JP2013530160A (ja) | 2010-01-20 | 2011-01-20 | 赤血球増加症治療用ａｎｔｉｍｉＲ−４５１ |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9340782B2 (https=) |
| EP (1) | EP2536436A4 (https=) |
| JP (1) | JP2013530160A (https=) |
| CN (1) | CN102869386A (https=) |
| WO (1) | WO2012148373A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2970968T3 (en) | 2013-03-15 | 2018-03-05 | Miragen Therapeutics Inc | CONNECTED BICYCLIC Nucleosides |
| US10517888B2 (en) | 2014-12-08 | 2019-12-31 | Thomas Jefferson University | Treatment and prevention of thrombosis using an anti-miR |
| US10306081B2 (en) * | 2015-07-09 | 2019-05-28 | Turner Broadcasting System, Inc. | Technologies for generating a point-of-view video |
| ES2659845B1 (es) | 2016-09-19 | 2019-01-04 | Univ Valencia | Modulación de microRNAs contra la distrofia miotónica tipo 1 y antagonistas de microRNAs para ello |
| CN113332434B (zh) * | 2021-05-25 | 2023-09-05 | 大连医科大学 | miR-451a调节剂在制备调控血压制剂中的应用 |
| WO2023194641A1 (es) | 2022-04-06 | 2023-10-12 | Universitat De València | Antagonistas de los microrna humanos mir-100, mir-20, mir-222, mir-181, y mir-92 y usos de los mismos |
| CN115920054A (zh) * | 2022-12-23 | 2023-04-07 | 扬州大学 | miR-144/451作为靶点在治疗精神分裂症中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006119266A2 (en) * | 2005-04-29 | 2006-11-09 | Rockefeller University | Human micrornas and methods for inhibiting same |
| EP2007888A2 (en) | 2006-04-03 | 2008-12-31 | Santaris Pharma A/S | Pharmaceutical composition comprising anti-mirna antisense oligonucleotides |
| WO2009137807A2 (en) | 2008-05-08 | 2009-11-12 | Asuragen, Inc. | Compositions and methods related to mirna modulation of neovascularization or angiogenesis |
| US8222221B2 (en) * | 2008-06-04 | 2012-07-17 | The Board Of Regents Of The University Of Texas System | Modulation of gene expression through endogenous small RNA targeting of gene promoters |
-
2011
- 2011-01-20 EP EP11856627.2A patent/EP2536436A4/en not_active Withdrawn
- 2011-01-20 WO PCT/US2011/021886 patent/WO2012148373A1/en not_active Ceased
- 2011-01-20 CN CN2011800142685A patent/CN102869386A/zh active Pending
- 2011-01-20 JP JP2013512611A patent/JP2013530160A/ja active Pending
- 2011-01-20 US US13/574,398 patent/US9340782B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013530160A5 (https=) | ||
| JP2008510019A5 (https=) | ||
| US20160122764A1 (en) | Respiratory disease-related gene specific sirna, double-helical oligo rna structure containing sirna, compositon containing same for preventing or treating respiratory disease | |
| JP2016506240A5 (https=) | ||
| JP2016116520A5 (https=) | ||
| CN105378083B (zh) | 修饰的TGF-β寡核苷酸 | |
| JP2012050438A5 (https=) | ||
| RU2014144630A (ru) | Композиции и способы ингибирования экспрессии гена alas1 | |
| JP2021506238A5 (https=) | ||
| JP2014513954A5 (https=) | ||
| JP2014508161A5 (https=) | ||
| RU2015151200A (ru) | Композиции и способы модулирования экспрессии аполипопротеина (а) | |
| JP2017538679A5 (https=) | ||
| JP2016520310A5 (https=) | ||
| JP2016522817A5 (https=) | ||
| JP2008514223A5 (https=) | ||
| CN103080314A (zh) | 显性突变基因表达抑制剂 | |
| JP2015518373A5 (https=) | ||
| BR112016023004B1 (pt) | Sirna, estrutura oligo rna de fita dupla, nanopartícula, composição farmacêutica e estrutura liofilizada para prevenir ou tratar fibrose ou doenças respiratórias contendo a mesma | |
| JP2014501492A5 (https=) | ||
| JP2014530004A5 (https=) | ||
| JP2015511821A5 (https=) | ||
| JP2014516027A5 (https=) | ||
| JP2014503192A5 (https=) | ||
| JP2014504865A5 (https=) |